Caspofungin IBIGEN Pdr/Conc/Soln for Infus 50mg Malta - anglų - Medicines Authority

caspofungin ibigen pdr/conc/soln for infus 50mg

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Caspofungin IBIGEN Pdr/Conc/Soln for Infus 70mg Malta - anglų - Medicines Authority

caspofungin ibigen pdr/conc/soln for infus 70mg

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Caspofungin Anfarm 50 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin anfarm 50 mg powder for concentrate for solution for infusion

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Caspofungin Anfarm 70 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin anfarm 70 mg powder for concentrate for solution for infusion

anfarm hellas s.a. 4 achaias str. & trizinias 14564 kifissia, attiki, greece - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Caspofungin 50 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin 50 mg powder for concentrate for solution for infusion

ethypharm 194 bureaux de la colline, bâtiment d, 92213 saint-cloud cedex, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Caspofungin 70 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin 70 mg powder for concentrate for solution for infusion

ethypharm 194 bureaux de la colline, bâtiment d, 92213 saint-cloud cedex, france - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

Caspofungin 50 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin 50 mg powder for concentrate for solution for infusion

centrient pharmaceuticals netherlands b.v (dsm sinochem) alexander fleminglaan 1, 2613 ax delft, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 50 mg - antimycotics for systemic use

Caspofungin 70 mg powder for concentrate for solution for infusion Malta - anglų - Medicines Authority

caspofungin 70 mg powder for concentrate for solution for infusion

centrient pharmaceuticals netherlands b.v (dsm sinochem) alexander fleminglaan 1, 2613 ax delft, netherlands - caspofungin acetate - powder for concentrate for solution for infusion - caspofungin acetate 70 mg - antimycotics for systemic use

CANCIDAS- caspofungin acetate injection, powder, lyophilized, for solution Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

cancidas- caspofungin acetate injection, powder, lyophilized, for solution

merck sharp & dohme corp. - caspofungin acetate (unii: vuw370o5qe) (caspofungin - unii:f0xdi6zl63) - caspofungin 1 kg in 1 kg

CASPOCIP caspofungin (as acetate) 70 mg powder for injection vial Australija - anglų - Department of Health (Therapeutic Goods Administration)

caspocip caspofungin (as acetate) 70 mg powder for injection vial

cipla australia pty ltd - caspofungin acetate, quantity: 77.69 mg (equivalent: caspofungin, qty 70 mg) - injection, powder for - excipient ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide - caspocip is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies